PAMCX | VEXAX | PAMCX / VEXAX | |
Total Expense Ratio | 1.01 | 0.05 | 2,020% |
Annual Report Gross Expense Ratio | 1.01 | 0.05 | 2,020% |
Fund Existence | 26 years | 25 years | - |
Gain YTD | 2.256 | 10.112 | 22% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.1B | 83.7B | 31% |
Annual Yield % from dividends | 0.00 | 1.10 | - |
Returns for 1 year | -8.20 | 11.65 | -70% |
Returns for 3 years | 17.07 | 58.64 | 29% |
Returns for 5 years | -6.56 | 52.04 | -13% |
Returns for 10 years | 23.83 | 152.21 | 16% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 154.19 | 0.77 | +0.50% |
iShares Biotechnology ETF | |||
ZJAN | 26.91 | 0.05 | +0.17% |
Innovator Equity Defined Protection ETF - 1 Yr January | |||
ILTB | 51.22 | -0.08 | -0.17% |
iShares Core 10+ Year USD Bond ETF | |||
MGMT | 42.97 | -0.48 | -1.10% |
Ballast Small/Mid Cap ETF | |||
VNAM | 24.45 | -0.51 | -2.04% |
Global X MSCI Vietnam ETF |